Chad A. Mirkin, the inaugural recipient of the Raymond and Beverly Sackler Prize in Convergence Research, was awarded the prize in a ceremony held in Washington, DC on Tuesday, October 13. Mirkin received the $400,000 prize “for impressively integrating chemistry, materials science, molecular biology, and biomedicine in the development of spherical nucleic acids that are widely used in the rapid and automated diagnosis of infectious diseases and many other human diseases -- including cancers and cardiac disease -- and in the detection of drug-resistant bacteria.